Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus

gan Ono-Nita, Suzane Kioko, Kato, Naoya, Shiratori, Yasushi, Carrilho, Flair José, Omata, Masao
Cyhoeddwyd 2002

Searching for chronic hepatitis B patients in a low prevalence area – role of racial origin

gan Ono-Nita, Suzane Kioko, Carrilho, Flair José, Cardoso, Rita A, Nita, Marcelo Eidi, da Silva, Luiz Caetano
Cyhoeddwyd 2004

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors

gan Ono-Nita, Suzane Kioko, Kato, Naoya, Shiratori, Yasushi, Lan, Keng-Hsin, Yoshida, Hideo, Carrilho, Flair José, Omata, Masao
Cyhoeddwyd 1999

Bcl‐X(L) Antisense Sensitizes Human Colon Cancer Cell Line to 5‐Fluorouracil

gan Nita, Marcelo Eidi, Ono‐Nita, Suzane Kioko, Tsuno, Nelson, Tominaga, Osamu, Takenoue, Tomohiro, Sunami, Eiji, Kitayama, Joji, Nakamura, Yusuke, Nagawa, Hirokazu
Cyhoeddwyd yn Jpn J Cancer Res (2000)

Genetic Risk for Alcoholic Chronic Pancreatitis

gan da Costa, Marianges Zadrozny Gouvêa, Guarita, Dulce Reis, Ono-Nita, Suzane Kioko, Paranaguá-Vezozzo, Denise Cerqueira, Felga, Guilherme Eduardo Gonçalves, Pedroso, Martha Regina Arcon, de Souza, Marcelo Moreira Tavares, Nasser, Paulo Dominguez, Ferreira, Camila da Silva, Carrilho, Flair José
Cyhoeddwyd 2011